Decalcification of the mitral annulus: surgical experience in 81 patients

M Dietrich1, M Doss, T Aybek

  • 1JWG Universitätsklinik Frankfurt am Main, THG-Chirurgie, Frankfurt am Main, Germany. md.md@gmx.de

Insights

Mitral annulus decalcification during valve surgery is challenging but feasible. This procedure, despite risks, yields good clinical outcomes for patients with severe mitral annular calcification.

Area of Science:

  • Cardiovascular Surgery
  • Cardiac Valve Disease
  • Mitral Valve Repair and Replacement

Background:

  • Extensive mitral annular calcification (MAC) presents significant technical challenges in mitral valve surgery.
  • MAC increases perioperative risks, complicating both mitral valve repair and replacement procedures.

Purpose of the Study:

  • To review the clinical experience and outcomes of mitral valve surgery involving decalcification of the mitral annulus.
  • To assess the feasibility and efficacy of decalcification in patients with extensive MAC undergoing mitral valve reconstruction or replacement.

Main Methods:

  • Retrospective analysis of 81 patients (mean age 64 years) with extensive MAC undergoing mitral valve repair or replacement between 1995 and 2003.
  • Procedures included mitral valve repair (n=42), biological replacement (n=20), and mechanical replacement (n=19).
  • Mean follow-up was 24 months, with a mean EuroSCORE of 7; 62% had concomitant procedures.

Main Results:

  • High perioperative survival (97.5%) and hospital survival (91.3%) were observed.
  • Two-year survival was 88.9%, with 90.2% freedom from reoperation.
  • Complications included reexploration for bleeding (n=8) and prolonged mechanical ventilation (n=5); no perioperative strokes occurred.

Conclusions:

  • Mitral valve surgery with decalcification of the mitral annulus can be performed successfully in patients with extensive calcification.
  • Despite elevated perioperative risks and potential need for reoperation, the procedure offers good clinical results.
  • This approach provides a viable option for managing complex mitral valve disease associated with severe MAC.
Abstract

Related Concept Videos

Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
Mitral Valve Prolapse II: Assessment and Management01:22

Mitral Valve Prolapse II: Assessment and Management

IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular tachycardia.
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...